Show simple item record

dc.contributor.authorJames, Philip
dc.contributor.authorConnolly, Katherine D.
dc.contributor.author
dc.contributor.authorWillis, Gareth R.
dc.contributor.authorDatta, Dev B.N.
dc.contributor.authorEllins, Elizabeth A.
dc.contributor.authorLadell, Kirsten
dc.contributor.authorPrice, David A
dc.contributor.authorGuschina, Irina A.
dc.contributor.authorRees, D. Aled
dc.date.accessioned2016-03-10T12:59:16Z
dc.date.available2016-03-10T12:59:16Z
dc.date.issued2014
dc.identifier.citationConnolly, K.D., Willis, G.R., Datta, D.B., Ellins, E.A., Ladell, K., Price, D.A., Guschina, I.A., Rees, D.A. and James, P.E. (2014) 'Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia', Journal of Lipid Research, 55(10), pp.2064-2072.en_US
dc.identifier.issn0022-2275
dc.identifier.urihttp://hdl.handle.net/10369/7751
dc.descriptionThis article was published in Journal of Lipid Research on 13 August 2014 (online), available at http://dx.doi.org/10.1194/jlr.M049726 Author's choice paid open accessen_US
dc.description.abstractLipoprotein-apheresis (apheresis) removes LDL-cholesterol in patients with severe dyslipidemia. However, reduction is transient, indicating that the long-term cardiovascular benefits of apheresis may not solely be due to LDL removal. Microparticles (MPs) are submicron vesicles released from the plasma membrane of cells. MPs, particularly platelet-derived MPs, are increasingly being linked to the pathogenesis of many diseases. We aimed to characterize the effect of apheresis on MP size, concentration, cellular origin, and fatty acid concentration in individuals with familial hypercholesterolemia (FH). Plasma and MP samples were collected from 12 individuals with FH undergoing routine apheresis. Tunable resistive pulse sensing (np200) and nanoparticle tracking analysis measured a fall in MP concentration (33 and 15%, respectively; P < 0.05) pre- to post-apheresis. Flow cytometry showed MPs were predominantly annexin V positive and of platelet (CD41) origin both pre- (88.9%) and post-apheresis (88.4%). Fatty acid composition of MPs differed from that of plasma, though apheresis affected a similar profile of fatty acids in both compartments, as measured by GC-flame ionization detection. MP concentration was also shown to positively correlate with thrombin generation potential. In conclusion, we show apheresis nonselectively removes annexin V-positive platelet-derived MPs in individuals with FH. These MPs are potent inducers of coagulation and are elevated in CVD; this reduction in pathological MPs could relate to the long-term benefits of apheresis.en_US
dc.language.isoenen_US
dc.publisherAmerican Society for Biochemistry and Molecular Biologyen_US
dc.relation.ispartofseriesJournal of Lipid Research;
dc.rightsCreative Commons Attribution Unported Licence
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.subjectextracellular vesiclesen_US
dc.subjectmicrovesiclesen_US
dc.subjectexosomesen_US
dc.subjectLDL-apheresisen_US
dc.subjectphosphatidylserineen_US
dc.subjectnanoparticleen_US
dc.subjecttracking analysisen_US
dc.subjecttuneable resistive pulse sensingen_US
dc.subjectflow cytometryen_US
dc.subjectfatty acidsen_US
dc.titleLipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemiaen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1194/jlr.M049726
dc.date.dateAccepted2014-05-05


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following collection(s)

Show simple item record

Creative Commons Attribution Unported Licence
Except where otherwise noted, this item's license is described as Creative Commons Attribution Unported Licence